Among them, 6 genes (CYCS, IL1A, IL6, PRKACA, NLRP2, and NLRP7) were downregulated, and 21 other genes (BAK1, BAX, CASP1, CASP3, CASP4, CHMP2A, CHMP4A, CHMP6, GSDMD, GSDME, HMGB1, IL18, IRF2, TP53, AIM2, CASP6, CASP9, NOD1, NOD2, SCAF11, and PYCARD) were enriched in the glioma group. This evidence concerns the gene IL1A and central nervous system cancer.